NDC 51144-001

TUKYSA

Tucatinib

TUKYSA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Seagen Inc.. The primary component is Tucatinib.

• Product ID: 51144-001_74cd362f-e2e4-4f5d-8885-29f5a973e040
• NDC: 51144-001
• Product Type: Human Prescription Drug
• Proprietary Name: TUKYSA
• Generic Name: Tucatinib
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2020-04-17
• Marketing Category: NDA / NDA
• Application Number: NDA213411
• Labeler Name: SEAGEN INC.
• Substance Name: TUCATINIB
• Active Ingredient Strength: 50 mg/1
• Pharm Classes: Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 51144-001-60

60 TABLET in 1 BOTTLE (51144-001-60)

• Marketing Start Date: 2020-04-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51144-001-60 [51144000160]

TUKYSA TABLET

• Marketing Category: NDA
• Application Number: NDA213411
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2020-04-17

Drug Details

Active Ingredients

Ingredient	Strength
TUCATINIB	50 mg/1

NDC Crossover Matching brand name "TUKYSA" or generic name "Tucatinib"

NDC	Brand Name	Generic Name
51144-001	TUKYSA	tucatinib
51144-002	TUKYSA	tucatinib